Nutra Pharma Corp(NPHC)

Description: Nutra Pharma Corp. is a biopharmaceutical company. The Company is engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. The Company's subsidiary and drug discovery arm, ReceptoPharm, Inc. (ReceptoPharm), carries its homeopathic and drug discovery research and clinical development and has developed homeopathic drugs for the treatment of pain: Cobroxin, an over-the-counter pain reliever designed to treat moderate to severe (Stage II) chronic pain; Nyloxin and Nyloxin Extra Strength, stronger versions of Cobroxin, and Pet Pain-Away, an over-the-counter pain reliever designed to treat pain in cats and dogs. It has developed two drug candidates: RPI-78M, to treat neurological diseases and autoimmune diseases, and RPI-MN, to treat viral diseases.

---

Keywords: Medicine Cancer Biopharmaceutical Pharmaceutical Products Pain Medication Infectious Diseases Drug Discovery Autoimmune Disease Neurological Disorders Chronic Pain Autoimmunity Urological Disorders Viral Disease Ronge Pseudoscience Neurological Diseases Neurological Disorder Autoimmune And Infectious Diseases Homeopathy Urological Diseases Autoimmune And Infectious Disease Consumer Fraud

---

Home Page: www.nutrapharma.com

1537 NW 65th Avenue
Plantation, FL 33313
United States
Phone: 954 509 0911

---

Officers

Exchange: OTCCE

Country: US

Currency: US Dollar ($)